Skip to main content
Log in

Neonatal citrullinaemia with satisfactory mental development

  • Metabolic Diseases
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In an infant with neonatal citrullinaemia therapy was instituted on day 1 of life with a low-protein diet and oral supplements of arginine, α-keto-acids, essential amino acids and carnitine. The latter may have contributed to the excellent clinical outcome, as evidenced by normal growth and satisfactory psychomotor development at 3 years of age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Batshaw M, Brusilow SW (1980) Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr 97:893–900

    PubMed  Google Scholar 

  2. Buist NRM, Kennaway NG, Hepburn CA, Strandholm JJ, Ramberg DA (1974) Citrullinemia: investigation and treatment over a four-year period. J Pediatr 85:208–214

    PubMed  Google Scholar 

  3. Costell M, Miguez MP, O'Connor JE, Grisolía S (1987) Effect of hyperammonemia on the levels of carnitine in mice. Neurology 37:804–808

    PubMed  Google Scholar 

  4. Danks DM, Tippet P, Zetner G (1974) Severe neonatal citrullinemia. Arch Dis Child 49:579–581

    PubMed  Google Scholar 

  5. Kleijer WJ, Thoomes R, Galjaard H, Wendel U, Fowler B (1984) First-trimester (chorion biopsy) diagnosis of citrullinemia and methylmalonicacidurie. Lancet II:1340

    Google Scholar 

  6. Laub MC, Paetzke-Brunner I, Jaeger G (1986) Serum carnitine during valproic acid therapy. Epilepsia 27:559–562

    PubMed  Google Scholar 

  7. Mori T, Tsochiyama A, Nagai K, Nagao M, Oyanagi K, Tsugawa S (1990) A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency-l-carnitine treatment of CSPI deficiency. Eur J Pediatr 149:272–274

    PubMed  Google Scholar 

  8. O'Connor JE, Costell M, Grisolía S (1987) The potentiation of ammonia toxicity by sodium benzoate is prevented byl-carnitine. Biochem Biophys Res Commun 145:817–824

    PubMed  Google Scholar 

  9. Ohtani Y, Ohyanagi K, Yamamoto S, Matsuda I (1988) Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency. J Pediatr 112:409–414

    PubMed  Google Scholar 

  10. Plasse M, Serre JC, Joannard A, Favier A, Grandgeorges D, Frappat P, Bost M (1980) Forme néonatale svére de citrullinémie, difficulté de la mise en évidence de l'héterozygotie. Interêt du dépistage anténatal. Ann Pédiatr 27:491–496

    Google Scholar 

  11. Roe CP, Bohan TP (1982)l-carnitine therapy in propionic-acidemia. Lancet I:1141–1142

    Google Scholar 

  12. Seccombe DW, Snyder F, Parson HG (1982)l-carnitine for methylmalonicaciduria. Lancet II:1401–1402

    Google Scholar 

  13. Tenenbaum D, Petion AM, Desgres J, Nivelon-Chevalier A, Gambert P, Nivelon JL (1987) Traitement de la citrullinémie. A propos d'un cas pris en charge dès la naissance. Interêt des acides alpha-cétoniques. Arch Fr Pediatr 44:855–861

    PubMed  Google Scholar 

  14. Thoene J, Batshaw M, Spector E (1977) Neonatal citrullinemia: treatment with ketoanalogues of essential amino acids. J Pediatr 90:218–224

    PubMed  Google Scholar 

  15. Walser M, Batshaw M, Sherwood G, Robinson B, Brusilow S (1977) Nitrogen metabolism in neonatal citrullinemia. Clin Sci Mol Med 53:173–181

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanjurjo, P., Rodríguez-Soriano, J., Vallo, A. et al. Neonatal citrullinaemia with satisfactory mental development. Eur J Pediatr 150, 730–731 (1991). https://doi.org/10.1007/BF01958766

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01958766

Key words

Navigation